Denali Therapeutics Inc. - COM (DNLI)

Historical Portfolio Holders from Q4 2017 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
116 M
Holdings value Q1 2024
$2.37 B
Value change Q1 2024
+$123 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
196
Number of buys Q1 2024
103
Number of sells Q1 2024
-100
Average buys Q1 2024 %
+0.001%
Average sells Q1 2024 %
-0.001%
CUSIP
24823R105
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 116 M $2.37 B +$123 M $20.52 197
2023 Q4 110 M $2.35 B +$35.3 M $21.46 202
2023 Q3 108 M $2.22 B +$10.9 M $20.63 191
2023 Q2 107 M $3.15 B -$962 K $29.51 193
2023 Q1 108 M $2.48 B +$45.5 M $23.04 192
2022 Q4 106 M $2.94 B +$355 M $27.81 188
2022 Q3 91.5 M $2.81 B -$38.2 M $30.69 186
2022 Q2 92.1 M $2.71 B +$189 M $29.43 169
2022 Q1 86.5 M $2.78 B +$41.7 M $32.17 169
2021 Q4 85.2 M $3.8 B +$12.2 M $44.60 200
2021 Q3 84.8 M $4.28 B +$170 M $50.45 205
2021 Q2 77.7 M $6.1 B +$34 M $78.44 206
2021 Q1 77.7 M $4.44 B +$73.6 M $57.10 209
2020 Q4 65.8 M $5.51 B +$204 M $83.76 197
2020 Q3 82.5 M $2.96 B +$14.8 M $35.83 163
2020 Q2 82.6 M $2 B +$63.5 M $24.18 137
2020 Q1 80.1 M $1.4 B +$148 M $17.51 120
2019 Q4 70.7 M $1.23 B -$9.09 M $17.42 105
2019 Q3 63.1 M $967 M -$4.83 M $15.32 108
2019 Q2 71.3 M $1.48 B +$62.5 M $20.76 109
2019 Q1 68.8 M $1.6 B +$23.5 M $23.22 110
2018 Q4 68 M $1.41 B -$870 K $20.66 84
2018 Q3 67 M $1.46 B +$109 M $21.74 75
2018 Q2 62.2 M $949 M +$18.8 M $15.25 66
2018 Q1 60.8 M $1.2 B +$60.2 M $19.69 56
2017 Q4 58.1 M $909 M +$768 M $15.64 44